Immunome, Inc. (IMNM)
21.50
-0.64
(-2.89%)
USD |
NASDAQ |
Feb 20, 16:00
21.51
+0.01
(+0.05%)
After-Hours: 20:00
Immunome SG&A Expense (Quarterly) : 10.94M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Prelude Therapeutics, Inc. | 5.21M |
| Eli Lilly & Co. | 3.132B |
| Relay Therapeutics, Inc. | 12.13M |
| Context Therapeutics, Inc. | 1.888M |
| Moderna, Inc. | 308.00M |